[Ovid] Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report

FTA_2025 Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-30 13:25
Reward10points

journalㄩAnti-Cancer Drugs

AuthorsㄩOnur Alkan; Ahmet Bagze; smail Nazli

Published dateㄩ--

DOIㄩ10.1097/cad.0000000000001833

PDF linkㄩhttps://journals.lww.com/10.1097/CAD.0000000000001833

Article linkㄩhttps://doi.org/10.1097/cad.0000000000001833

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


RemarkㄩPlease provide article pdf on urgent basis
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list